uniQure (QURE) Other Accumulated Expenses (2015 - 2026)
uniQure (QURE) recorded quarterly Other Accumulated Expenses of $224000.0 in Q1 2026, down 5.08% quarter-over-quarter from $236000.0 in Q4 2025.
uniQure (QURE) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
uniQure's Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $224000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $224000.0; the TTM figure through Mar 2026 stood at $224000.0 (changed N/A YoY), while the FY2025 annual figure was $236000.0, down 19.45% from the prior year.
- Other Accumulated Expenses was $224000.0 for Q1 2026 at uniQure, down from $236000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $2.2 million in Q4 2022 to a low of $224000.0 in Q1 2026.
- Historically, Other Accumulated Expenses has averaged $1.1 million across 5 years, with a median of $708500.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses dropped 21.66% in 2022, then fell 19.45% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $2.2 million in 2022, then changed by 0.0% to $2.2 million in 2023, then plunged by 86.98% to $293000.0 in 2024, then dropped by 19.45% to $236000.0 in 2025, then fell by 5.08% to $224000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $224000.0 (Q1 2026), $236000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224,000.00 |
| Dec 31, 2025 | 236,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Dec 31, 2024 | 293,000.00 |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Mar 31, 2021 | 5.00 Mn |
| Dec 31, 2020 | 2.08 Mn |
| Dec 31, 2018 | 545,000.00 |
| Sep 30, 2018 | 836,000.00 |
| Jun 30, 2018 | 861,000.00 |
| Mar 31, 2018 | 440,000.00 |
| Dec 31, 2017 | 844,000.00 |
| Sep 30, 2017 | 2.45 Mn |
| Jun 30, 2017 | 2.37 Mn |
| Mar 31, 2017 | 30,000.00 |
| Dec 31, 2016 | 383,000.00 |
| Dec 31, 2015 | 574,000.00 |